Procagen Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $9.8M

Procagen General Information

Description

Developer of a genetic analysis technology designed to enable disease prediction, diagnosis, and management of male urinary conditions. The company offers artificial intelligence driven analysis of clinical, genomic, and imaging data with predictive algorithms for urinary tumors and male health conditions, enabling patients to receive personalized prevention and early screening programs for prostate cancer detection.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Semyeong Tower 501-2, 11 Jeongjail-ro
  • 156beon-gil, Bundang-gu
  • Seongnam, Gyeonggi 13558
  • South Korea
+82
Primary Industry
Decision/Risk Analysis
Other Industries
Diagnostic Equipment
Acquirer
Corporate Office
  • Semyeong Tower 501-2, 11 Jeongjail-ro
  • 156beon-gil, Bundang-gu
  • Seongnam, Gyeonggi 13558
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Procagen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 15-Jul-2022 $9.8M Completed Generating Revenue
4. Accelerator/Incubator 08-Jan-2022 Completed Generating Revenue
3. Accelerator/Incubator 01-Mar-2021 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2020 $60K Completed Generating Revenue
1. Seed Round 01-Jan-2019 $60K $60K Completed Generating Revenue
To view Procagen’s complete valuation and funding history, request access »

Procagen Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
ActnerLab Accelerator/Incubator Minority
Busan United Holdings Accelerator/Incubator Minority
IBK Changgong Accelerator/Incubator
Tech Incubator Program for Startup Accelerator/Incubator
To view Procagen’s complete investors history, request access »

Procagen FAQs

  • When was Procagen founded?

    Procagen was founded in 2018.

  • Where is Procagen headquartered?

    Procagen is headquartered in Seongnam, South Korea.

  • What industry is Procagen in?

    Procagen’s primary industry is Decision/Risk Analysis.

  • Is Procagen a private or public company?

    Procagen is a Private company.

  • What is the current valuation of Procagen?

    The current valuation of Procagen is .

  • What is Procagen’s current revenue?

    The current revenue for Procagen is .

  • How much funding has Procagen raised over time?

    Procagen has raised $60K.

  • Who are Procagen’s investors?

    ActnerLab, Busan United Holdings, IBK Changgong, and Tech Incubator Program for Startup have invested in Procagen.

  • When was Procagen acquired?

    Procagen was acquired on 15-Jul-2022.

  • Who acquired Procagen?

    Procagen was acquired by Invites Biocore.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process